Short, sourced articles on peptide science, quality control, storage and the European market. Published daily by the PeptideEuropa.com research desk.
KLOW-80 combines four complementary peptides—GHK-Cu, BPC-157, TB-500 and KPV—each targeting different growth factor and immune checkpoints to produce synergistic rather than redundant effects in tissue regeneration research.
Read articleBPC-157 and TB-500 operate through distinct but complementary mechanisms. When combined, their pathways converge on shared downstream signalling nodes to produce supra-additive effects on angiogenesis and collagen deposition.
Read articlePT-141 (bremelanotide) selectively activates melanocortin-4 receptors in hypothalamic circuits governing sexual motivation, avoiding the unwanted pigmentation caused by melanocortin-1 receptor activation seen with melanotan-2.
Read articleMelanotan-2 is a cyclic α-MSH analogue that darkens skin via MC1R activation but simultaneously engages MC3R and MC4R at the brainstem, producing unexpected appetite modulation from a single ligand structure.
Read articleSelank is a seven-amino-acid tuftsin analogue that produces anxiolytic effects not through occupying a single primary receptor, but by potentiating GABA signalling and upregulating brain-derived neurotrophic factor via indirect neuroimmune mechanisms.
Read articleBPC-157 lacks a known cognate receptor yet triggers tissue repair across tendon, muscle and gut. Recent mechanistic studies reveal integrin clustering and growth factor receptor cross-activation as the likely drivers.
Read articleIGF-1 LR3 escapes IGF-binding protein sequestration through two key structural changes: a 13-residue N-terminal extension and arginine substitution at position 3. This design preserves receptor activity while extending bioavailability in vitro.
Read articleHexarelin binds both the ghrelin receptor and CD36 scavenger receptors, triggering a cardioprotective cascade distinct from classical ghrelin agonism. This dual-pathway mechanism offers insight into non-classical receptor signalling in research models.
Read articleGHRP-6 and GHRP-2 are both ghrelin receptor agonists, yet their structural differences produce markedly different appetite signalling intensities. This article examines the molecular basis of receptor selectivity and binding affinity.
Read articleDispatched from the Netherlands · 99%+ HPLC purity · lot-specific CoA · 3–5 business days across the EU.